Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | AGXT | P21549 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 5/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 2/20 | 0.37 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9394469 | 0.88 | CYP1A2 (0.48) | IDO1AGXTCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL2383968 | 0.80 | KMT2A (0.53) | MMP2 | |
| SCHEMBL29482067 | 0.80 | KMT2A (0.53) | MMP2 | |
| SCHEMBL28243335 | 0.78 | KMT2A (0.52) | MMP2 | |
| SCHEMBL28319154 | 0.78 | GLA (0.43) | MAOB | |
| SCHEMBL14426950 | 0.76 | CYP1A2 (0.43) | IDO1AGXTCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL514257 | 0.74 | MMP2 (0.48) | IDO1AGXTMAOBTAAR1MMP2 | |
| SCHEMBL30515516 | 0.74 | MMP2 (0.48) | IDO1AGXTMAOBTAAR1MMP2 | |
| SCHEMBL18459892 | 0.74 | ATM (0.40) | MMP2 | |
| SCHEMBL1368311 | 0.74 | TAAR1 (0.50) | IDO1AGXTMAOBTAAR1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106986861-A | Antiviral compound | 艾伯维巴哈马有限公司 | 2017-07-28 | — | — | CN | disclosed |
| WO-1998033496-A1 | SULPHONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 1998-08-06 | — | — | WO | disclosed |